- Home
- VCIG vs BOLT Comparison
VCIG vs BOLT Comparison
Compare VCIG & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- BOLT
- Stock Information
- Founded
- VCIG 2013
- BOLT 2015
- Country
- VCIG Malaysia
- BOLT United States
- Employees
- VCIG N/A
- BOLT N/A
- Industry
- VCIG Diversified Commercial Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- BOLT Health Care
- Exchange
- VCIG Nasdaq
- BOLT Nasdaq
- Market Cap
- VCIG 15.6M
- BOLT 16.8M
- IPO Year
- VCIG 2023
- BOLT 2021
- Fundamental
- Price
- VCIG $4.18
- BOLT $0.35
- Analyst Decision
- VCIG
- BOLT Hold
- Analyst Count
- VCIG 0
- BOLT 5
- Target Price
- VCIG N/A
- BOLT $1.00
- AVG Volume (30 Days)
- VCIG 179.2K
- BOLT 103.8K
- Earning Date
- VCIG 05-13-2025
- BOLT 05-12-2025
- Dividend Yield
- VCIG 230.05%
- BOLT N/A
- EPS Growth
- VCIG N/A
- BOLT N/A
- EPS
- VCIG 54.73
- BOLT N/A
- Revenue
- VCIG $27,819,290.00
- BOLT $3,638,000.00
- Revenue This Year
- VCIG N/A
- BOLT N/A
- Revenue Next Year
- VCIG N/A
- BOLT $77.48
- P/E Ratio
- VCIG $0.09
- BOLT N/A
- Revenue Growth
- VCIG 36.99
- BOLT N/A
- 52 Week Low
- VCIG $2.30
- BOLT $0.30
- 52 Week High
- VCIG $1,097.60
- BOLT $1.34
- Technical
- Relative Strength Index (RSI)
- VCIG 38.37
- BOLT 45.53
- Support Level
- VCIG $5.01
- BOLT $0.35
- Resistance Level
- VCIG $6.05
- BOLT $0.38
- Average True Range (ATR)
- VCIG 0.72
- BOLT 0.03
- MACD
- VCIG 0.30
- BOLT 0.00
- Stochastic Oscillator
- VCIG 6.50
- BOLT 29.16
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.